These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 36635411)

  • 1. The role of immune cells and mediators in preeclampsia.
    Deer E; Herrock O; Campbell N; Cornelius D; Fitzgerald S; Amaral LM; LaMarca B
    Nat Rev Nephrol; 2023 Apr; 19(4):257-270. PubMed ID: 36635411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A leading role for the immune system in the pathophysiology of preeclampsia.
    Laresgoiti-Servitje E
    J Leukoc Biol; 2013 Aug; 94(2):247-57. PubMed ID: 23633414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
    Shah DA; Khalil RA
    Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert review: preeclampsia Type I and Type II.
    Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
    Possomato-Vieira JS; Khalil RA
    Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Different Lymphoid Cell Populations in Preeclampsia Pathophysiology.
    Campbell NE; Deer EM; Herrock OT; LaMarca BB
    Kidney360; 2022 Oct; 3(10):1785-1794. PubMed ID: 36514732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune responses in the pathophysiology of preeclampsia.
    Miller D; Motomura K; Galaz J; Gershater M; Lee ED; Romero R; Gomez-Lopez N
    J Leukoc Biol; 2022 Jan; 111(1):237-260. PubMed ID: 33847419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A; Rana S; Karumanchi SA
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
    Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preeclampsia and health risks later in life: an immunological link.
    Cheng SB; Sharma S
    Semin Immunopathol; 2016 Nov; 38(6):699-708. PubMed ID: 27339196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preeclampsia: oxidative stress, inflammation and endothelial dysfunction].
    de Oliveira LG; Karumanchi A; Sass N
    Rev Bras Ginecol Obstet; 2010 Dec; 32(12):609-16. PubMed ID: 21484030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hypertension and superimposed preeclampsia: screening and diagnosis.
    Kametas NA; Nzelu D; Nicolaides KH
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1182-S1195. PubMed ID: 35177217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia.
    Aneman I; Pienaar D; Suvakov S; Simic TP; Garovic VD; McClements L
    Front Immunol; 2020; 11():1864. PubMed ID: 33013837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of placental glycans and its role in regulating peripheral blood NK cells during preeclampsia: a perspective.
    Bueno-Sánchez JC; Gómez-Gutiérrez AM; Maldonado-Estrada JG; Quintana-Castillo JC
    Front Endocrinol (Lausanne); 2023; 14():1087845. PubMed ID: 37206444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia.
    Das UN
    Nutrition; 2015 Sep; 31(9):1083-95. PubMed ID: 26233865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early disturbed placental ischemia and hypoxia creates immune alteration and vascular disorder causing preeclampsia.
    Zárate A; Saucedo R; Valencia J; Manuel L; Hernández M
    Arch Med Res; 2014 Oct; 45(7):519-24. PubMed ID: 25450587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia.
    Rusterholz C; Hahn S; Holzgreve W
    Semin Immunopathol; 2007 Jun; 29(2):151-62. PubMed ID: 17621700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
    Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia: current understanding of the molecular basis of vascular dysfunction.
    Sankaralingam S; Arenas IA; Lalu MM; Davidge ST
    Expert Rev Mol Med; 2006 Jan; 8(3):1-20. PubMed ID: 16438753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia.
    Burton GJ; Yung HW; Cindrova-Davies T; Charnock-Jones DS
    Placenta; 2009 Mar; 30 Suppl A(Suppl):S43-8. PubMed ID: 19081132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.